According to Savara Pharmaceuticals's latest financial reports the company's total assets are $0.15 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.17 B | 27.03% |
2022-12-31 | $0.13 B | -20.85% |
2021-12-31 | $0.17 B | 80.67% |
2020-12-31 | $97.74 M | -28.24% |
2019-12-31 | $0.13 B | -10.56% |
2018-12-31 | $0.15 B | -4.6% |
2017-12-31 | $0.15 B | 451.7% |
2016-12-31 | $28.93 M | -46.63% |
2015-12-31 | $54.21 M | -23.1% |
2014-12-31 | $70.5 M | 27.6% |
2013-12-31 | $55.25 M | 17.62% |
2012-12-31 | $46.97 M | -24.06% |
2011-12-31 | $61.85 M | 117.14% |
2010-12-31 | $28.48 M | 215.57% |
2009-12-31 | $9.02 M | -15.71% |
2008-12-31 | $10.7 M | -69% |
2007-12-31 | $34.54 M | -34.58% |
2006-12-31 | $52.79 M | 123.52% |
2005-12-31 | $23.62 M | 73.58% |
2004-12-31 | $13.6 M | 217.71% |
2003-12-31 | $4.28 M | 3186.17% |
2002-12-31 | $0.13 M | -53.11% |
2001-12-31 | $0.27 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.97 B | 1,147.05% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $18.17 M | -88.52% | ๐บ๐ธ USA |